The Peptides Epidemic

Dr. Karan Rajan — The Peptides Epidemic

Channel: Dr Karan · Our label: Physician educator (NHS) — myth-busting voice · Source: youtube.com/watch?v=9wHFg1BWdOk

What this video covers

This may be the most controversial thing we have on this table. » This is a peptide » your skin to produce more [music] collagen. » Are you tired of aging like a normal human being? Sick of your skin, your joints, your entire cellular structure betraying you?

Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.

Key points, in the speaker’s own framing

• Despite each one of the FDA scientists reviewing the evidence and advising against every single peptide, the panel voted yes.

• To my knowledge, there is only one study on humans, and it’s not a clinical trial, and frankly, it’s not the best performed study, and that’s putting it mildly.

• The only human efficacy study the FDA could find when it reviewed BPC57 in July of 2026 was a conference abstract looking at 46 people where it was delivered as an enema.
• So remember, whenever you hear anyone talking about BPC57’s miraculous effects, virtually all of that evidence comes from animal studies, not humans.
• One thing we do know about BPC57 in animals is that it promotes angioenesis, the growth of new blood vessels, partly by increasing growth hormone or IGF-1 signaling.
• In 2023, the FDA put these peptides in a category, meaning do not compound, citing significant safety risks.

Read next

• BPC-157 — compound page
• GHK-Cu — more videos
• GLP-1 class — more videos
• IGF-1 — more videos
• All videos from this channel

Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.